Opening the active site to beta-lactam substrates also typically enhances the susceptibility of the enzyme to β-lactamase inhibitors, such as clavulanic acid.
A apertura do sitio activo a substratos beta-lactámicos tamén potencia normalmente a susceptibilidade do encima a inhibidores da β-lactamase, como o ácido clavulánico.